Open-Label Non-Interventional Evaluation of Efficacy of Crestor (Rosuvastatin) in Reduction of LDL-Cholesterol and Cardiovascular Risk Parameters in Patients With Hypercholesterolaemia.
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 12 Feb 2009 New trial record
- 05 Feb 2009 Trial phase is IV as reported by ClinicalTrials.gov.